FDA soon??? for ARA"An FDA filing is expected by 6/06 and ARA.TO’s stock should increase substantially if the regulatory filing
is made."
ARA.TO’s cash position of (CDN) $12.8m (plus $1.6m in receivables) should provide enough funds to operate
into Q4/07. An FDA filing is expected by 6/06 and ARA.TO’s stock should increase substantially if the regulatory filing
is made. ARA.TO’s cash position is strong and management is definitely focused on streamlining operations to reach
operational goals. Although progress is being made; we feel investors should maintain their current position and
probably should add to their position incrementally up to/until a regulatory filing for SoftScan® is made.